Member Info for Boonco

Good appointment but has less than no bearing on whether or not the fda gives parsortix the nod.

I’m sure before teatime is doable if they really wanted to do so, they are just unnecessarily dragging their feet like 4D.

For everyone else, yes that was sarcasm.

Off-topic I know but what the hell has happened on the 4D board, I had a quick look before here and it looks like it’s turned into a free for all sh*tshow!

Researcher, it would be nice if next year was a possibility but that's probably not realistic is it. First off it needs further and larger studies to be carried out.

Don't misunderstand me, I understand the frustration people have with timelines but for society as a whole it's best that things are done proper first time round. Get it wrong and it'll do more harm than good.

When they originally submitted to the fda they noted that the submission was also designed to meet requirements for European CE mark registration, something they would do if they get fda approval.

https://www.lse.co.uk/rns/AGL/angle-announces-completion-of-fda-submission-pm5y20p9vi4kprh.html

Angle have made a strategic decision to get fda approval first for numerous reasons and for Angle's business I agree with the decision. You don't have to get fda approval before seeking clearance elsewhere though, plenty of companies sell product for clinical use in Europe and elsewhere before they look to enter the US market. Some will operate elsewhere first because it might be easier to get clearance others because operating commercially in their home country first makes most sense.

Many argue fda is seen as global gold standard and generally it probably is is but it doesn't mean they always make the best or right decision on any given submission. I certainly know clinicians who I've worked in the UK and internationally with who I'm pretty sure would dispute the contention that fda is always the best barometer of judgment.

Link to the info about Toyota launching on 1st December?

Given they've previously said they expect production SSB car around mid-decade presumably what you're referring to but not noting is that it's the prototype, which is already known about to a limited extent?

Hey Michael,

If you would care to revisit your post the other day you'll note that you didn't say they may have had to refocus the trials, you said you think they've needed to refocus the trials. There's a difference and it was your reasoning behind your thinking that they’ve needed to refocus the trials that my post was in response to.

You'll also note that whilst I labelled your reasoning/thinking that they have had problems have needed to refocus the trial as pessimism, I also acknowledged that that doesn't mean you can't be right. I think it's fair to say that I wouldn't have acknowledged that it doesn't mean your thinking can't be right if I was coming from the less than honest motives perspective that I interpret you as insinuating - correct me on my interpretation if I’m wrong?

As for my claiming that the trial is going very well. It wasn’t a claim, it was an opinion. A claim is something yet to be verified as fact but made out to be such. Perhaps my reasoning wasn’t clear enough for you to make that distinction and if that’s the case then that’s on me. I was very clear in my response to Dave in the same thread though that what I said was an opinion and not a fact.

My motives should you be interested are that I am long on 4D and have high conviction. My conviction comes from my background enabling me to understand a lot of the heavy science. I’ve never traded stock in any company and as people will see if they look at the few past comments I’ve made on here I have no interest in the short term. My only interest is the operation and performance of a business as that is what counts in the long run.

A bit more reasoning behind my thinking for you is this. Dave referred to my talking about the mrx0518 plans mentioned in the corporate presentation as essentially being useless because they wouldn’t put bad news in there (I agreed with him that they wouldn’t). However, even if someone like Dave places little weight on the presentation as a source of insight, it is official communication by the company and management have a duty not to knowingly mislead investors.

With that context that they have a duty not to knowingly mislead in mind. There is currently one phase 2 trial ongoing for mrx0518, so when they note in the presentation that in 2022 they plan to “Advance MRx0518 into registration-targeted studies” I don’t think it unreasonable to reason that they wouldn’t say that if they have had problems in the phase 2 trial. If they’ve had problems that could knowingly put the above 2022 plan into question then it’s reasonable to consider that what they put in the presentation could leave them open to the charge of knowingly misleading. As far as I’m concerned they’ve been very good stewards of the business to date and as such I don’t think they would be irresponsible.

Again, it’s an opinion not a claim. It might turn out to be that I've fooled myself with a great example of confirmation bias.

I meant to add.

That the author refers to the S series as batteries also doesn't exactly inspire confidence in their work.

Quite possible, it was unquestionably over sold. It looks like whoever has been selling off decent chunks for a few weeks now is still continuing to do so though.

Short term is anyone's guess.
Long term looks bright.

The contention that Zeus’s current investment case is based on the S series appears to be at odds with what Zeus themselves say.

Zeus acknowledge the potential that the improved economics of the S series offers but they make it quite clear that their current valuation of 188p (i.e. their current investment case) doesn’t include consideration of the S series.

Here’s the concluding paragraph from their last note. Make up your own mind.

"Our note on 13 September (A Solid future) highlighted the enormous potential for the group’s products in Data Centres and Maritime markets but our 188p per share valuation is currently based on projected sales for high power EV charging in a handful of major markets and Distributed Power for customers such as the construction industry. The potential could be greatly enhanced by the improved economics of the S-series product."

I haven't listened to the interview but if he talked about the cost being expensive perhaps he was doing so to fire a shot across the bow of government so to speak i.e. you need to do more to encourage and help companies do the right thing

"Boonco you talk a load of crap. There are obvioulsy issues, hence the delays."

Dave, there's a difference between an opinion and a fact. Your belief that there are obviously problems is the former. My belief that there likely hasn't been any problems is also an opinion but one that I believe to be better reasoned.

"I wouldn't call a drop in SP from 60% reduction in SP in less than a year pestimistic, more realistic based on the lack and clarity and engagement from the company."

That's a straw man argument in relation to my post as I didn't say anything about or in anyway connected to the share price. But if you want to go there, you didn't really think that argument through did you. Think about what pessimistic means.

I disagree with you. Suck it up and move on as you'll be on my filtered list from now. Not because we disagree, I'd rather hang out with folk I disagree with on things rather than those whom agree on everything, but because I have no time for the childish name calling schoolyard nonsense your posting history suggests you enjoy.

Good luck whatever you do.

Agreed

“You seem to be confusing balanced presenting of arguments, by certain posters, with pessimism. The world is rarely just complete sunshine or heavy rain.”

Not at all Michael. You are choosing to interpret the lack of a comprehensive update on phase 2 as a sign that there have been problems with the trial. That’s pessimism. It doesn’t mean you can’t be right.

Pessimism and optimism aren’t inherently bad or good. Presumably you consider pessimism to be negative though which is why you seem to have taken my disagreement as criticism or a personal attack.

Clearly we approach how we think about the matter differently. You appear to be basing your thinking on the progress of phase 2 on what hasn’t been said, whilst I choose to base my thinking on what has been said.

Time will tell.

I'll be honest, I don't see reason for all the pessimism some hold.

In the recently updated corporate presentation management included a couple of bullet points on MRx0518 that can only be interpreted as things are progressing positively. The first bullet point was under 2021 the second and third points under 2022...

• Further engagement with regulators regarding pivotal studies
• Advance MRx0518 into registration-targeted studies
• Expand MRx0518 into earlier treatment settings

You don't tell investors any of those things if the current trials are going badly and need refocusing.

Who knows. It's no secret that ilika worked with Toyota for a while but then conventional lithium ion batteries have a generally believed theoretical ceiling on their performance regardless of the approach taken and who makes them.

My investment assumes in ilika assumes that Toyota are doing their own thing. If it turns out that i'm wrong then that'll be an unexpected bonus.

You forgot to note that they say a loss of only 10% is their target. In other words it’s not definite.

Regardless, that steady state technology offers better long-term performance than conventional lithium ion isn’t new news. It just reinforces the work that ilika are doing.

Graham Purdy interview with Proactive New York.

Nice to see them actively engaging more with the US since the listing on OTCQX.

https://www.proactiveinvestors.co.uk/companies/news/964620/ilika-describes-the-latest-progress-its-been-making-on-its-solid-state-battery-technology-products-964620.html

Won’t allow posting of link, see *************interviews website

https://www.***************************/ilika-roadmap-with-vp-of-sales-and-marketing-john-tinson-interview/4121029750

The Dalai Lama suggests people work to want what they have, not what they want. Maybe there’s a lesson in there about satisfaction.